Walleye Capital’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-14,183
| Closed | -$296K | – | 1916 |
|
2024
Q4 | $296K | Sell |
14,183
-234,105
| -94% | -$4.89M | ﹤0.01% | 1370 |
|
2024
Q3 | $4.94M | Buy |
+248,288
| New | +$4.94M | 0.01% | 447 |
|
2024
Q2 | – | Sell |
-21,302
| Closed | -$340K | – | 2702 |
|
2024
Q1 | $340K | Buy |
+21,302
| New | +$340K | ﹤0.01% | 1580 |
|
2023
Q4 | – | Sell |
-20,549
| Closed | -$240K | – | 2322 |
|
2023
Q3 | $240K | Buy |
20,549
+8,650
| +73% | +$101K | ﹤0.01% | 1420 |
|
2023
Q2 | $160K | Buy |
+11,899
| New | +$160K | ﹤0.01% | 1392 |
|
2020
Q2 | – | Sell |
-12,000
| Closed | -$46K | – | 624 |
|
2020
Q1 | $46K | Buy |
+12,000
| New | +$46K | 0.01% | 425 |
|